Safety and clinical activity of atezolizumab (anti-PDL1) in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer

被引：7

作者：

Adams, S.

Diamond, J.

Hamilton, E.

Pohlmann, P.

Tolaney, S.

Molinero, L.

Zou, W.

Liu, B.

Waterkamp, D.

Funke, R.

Powderly, J.

机构：

[1] NYU, Langone Med Ctr, New York, NY USA

[2] Univ Colorado, Anschutz Med Campus, Aurora, CO USA

[3] Sarah Cannon Res Inst, Nashville, TN USA

[4] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Genentech Inc, S San Francsico, CA USA

[7] Carolina BioOncol Inst, Huntersville, NC USA

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS15-P2-11-06

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2-11-06

引用

页数：2